332 related articles for article (PubMed ID: 25750061)
1. Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
Blum K; Febo M; Thanos PK; Baron D; Fratantonio J; Gold M
Mol Neurobiol; 2015 Dec; 52(3):1862-1869. PubMed ID: 25750061
[TBL] [Abstract][Full Text] [Related]
2. Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis.
Blum K; Modestino EJ; Neary J; Gondré-Lewis MC; Siwicki D; Moran M; Hauser M; Braverman ER; Baron D; Steinberg B; Laughlin TM; Badgaiyan RD
Biomed J Sci Tech Res; 2018 Jan; 2(2):1-4. PubMed ID: 30370423
[TBL] [Abstract][Full Text] [Related]
3. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).
Blum K; Chen TJ; Downs BW; Bowirrat A; Waite RL; Braverman ER; Madigan M; Oscar-Berman M; DiNubile N; Stice E; Giordano J; Morse S; Gold M
Postgrad Med; 2009 Nov; 121(6):176-96. PubMed ID: 19940429
[TBL] [Abstract][Full Text] [Related]
4. A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.
Gold MS; Badgaiyan RD; Blum K
Psychiatr Clin North Am; 2015 Sep; 38(3):419-62. PubMed ID: 26300032
[TBL] [Abstract][Full Text] [Related]
5. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
[TBL] [Abstract][Full Text] [Related]
6. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
Blum K; Gold MS
Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
[TBL] [Abstract][Full Text] [Related]
7. Reward deficiency syndrome: genetic aspects of behavioral disorders.
Comings DE; Blum K
Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
[TBL] [Abstract][Full Text] [Related]
8. Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.
Blum K; Chen AL; Oscar-Berman M; Chen TJ; Lubar J; White N; Lubar J; Bowirrat A; Braverman E; Schoolfield J; Waite RL; Downs BW; Madigan M; Comings DE; Davis C; Kerner MM; Knopf J; Palomo T; Giordano JJ; Morse SA; Fornari F; Barh D; Femino J; Bailey JA
Int J Environ Res Public Health; 2011 Dec; 8(12):4425-59. PubMed ID: 22408582
[TBL] [Abstract][Full Text] [Related]
9. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
[TBL] [Abstract][Full Text] [Related]
10. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).
Blum K; Baron D; McLaughlin T; Gold MS
J Neurol Sci; 2020 Apr; 411():116733. PubMed ID: 32088516
[TBL] [Abstract][Full Text] [Related]
11. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
[TBL] [Abstract][Full Text] [Related]
12. Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape.
Blum K; Febo M; Badgaiyan RD; Demetrovics Z; Simpatico T; Fahlke C; M OB; Li M; Dushaj K; Gold MS
Curr Neuropharmacol; 2017; 15(1):184-194. PubMed ID: 27174576
[TBL] [Abstract][Full Text] [Related]
13. Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction.
Blum K; Thanos PK; Oscar-Berman M; Febo M; Baron D; Badgaiyan RD; Gardner E; Demetrovics Z; Fahlke C; Haberstick BC; Dushaj K; Gold MS
J Reward Defic Syndr; 2015; 1(3):95-104. PubMed ID: 27398406
[TBL] [Abstract][Full Text] [Related]
14. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.
Blum K; Chen AL; Chen TJ; Braverman ER; Reinking J; Blum SH; Cassel K; Downs BW; Waite RL; Williams L; Prihoda TJ; Kerner MM; Palomo T; Comings DE; Tung H; Rhoades P; Oscar-Berman M
Theor Biol Med Model; 2008 Nov; 5():24. PubMed ID: 19014506
[TBL] [Abstract][Full Text] [Related]
15. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
[TBL] [Abstract][Full Text] [Related]
16. "Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry.
Blum K; Gardner E; Oscar-Berman M; Gold M
Curr Pharm Des; 2012; 18(1):113-8. PubMed ID: 22236117
[TBL] [Abstract][Full Text] [Related]
17. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
[TBL] [Abstract][Full Text] [Related]
18. Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial.
Blum K; Febo M; Badgaiyan RD
Austin Addict Sci; 2016; 1(2):. PubMed ID: 27840857
[TBL] [Abstract][Full Text] [Related]
19. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.
Blum K; Braverman ER; Holder JM; Lubar JF; Monastra VJ; Miller D; Lubar JO; Chen TJ; Comings DE
J Psychoactive Drugs; 2000 Nov; 32 Suppl():i-iv, 1-112. PubMed ID: 11280926
[TBL] [Abstract][Full Text] [Related]
20. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
